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Background: Chronic hyperglycemia (CHG) with HbA1c as an indicator affects postoperative mortality and morbidity
after coronary artery bypass grafting surgery (CABG). Acute kidney injury (AKI) is one of the frequent postoperative
complications after CABG impacting short-and long-term outcomes. We investigated the association between CHG
and postoperative incidence of AKI in CABG patients with and without history of diabetes mellitus (DM).
Methods: This cohort study consecutively enrolled patients undergoing CABG in 2009 at the department for
cardiovascular surgery. CHG was defined as HbA1c ≥ 6.0 %. Patients with advanced chronic kidney disease (CKD)
were excluded. The incidence of postoperative AKI and its association with CHG was analyzed by univariate and
multivariate logistic regression modeling.
Results: Three-hundred-seven patients were analyzed. The incidence of AKI was 48.2 %. Patients with CHG (n = 165)
were more likely to be female and had greater waist circumference as well as other comorbid conditions, such as
smoking, history of DM, CKD, hypertension, pulmonary hypertension, and chronic obstructive pulmonary disease
(all p≤ 0.05). Preoperative eGFR, atrial fibrillation (AF), history of DM and CHG were associated with an increased risk of
postoperative AKI in univariate analyses. In multivariate modelling, history of DM as well as preoperative eGFR and AF lost
significance, while age, CHG and prolonged OP duration (p < 0.05) were independently associated with postoperative AKI.
Conclusions: Our results suggest that CHG defined on a single measurement of HbA1c≥ 6.0 % was associated with the
incidence of AKI after CABG. This finding might implicate that treatment decisions, including the selection of operative
strategies, could be based on HbA1c measurement rather than on a recorded history of diabetes.Background
Acute kidney injury (AKI) is a frequent postoperative
complication with an incidence ranging from 20 to 40 %
in patients undergoing cardiac surgery [1–6]. Even slight
changes in creatinine-levels, e.g. by 0.3 mg/dl (AKI Stage
I [7]), are associated with impaired long-term outcome,
such as risk of mortality or development or progression
of chronic kidney disease (CKD), as multiple studies
have indicated in CABG patients [4–6, 8]. Age, gender,
preoperative creatinine, diabetes mellitus (DM), and
metabolic syndrome, but also urgent operations and* Correspondence: Oezkur_m@ukw.de
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unless otherwise stated.operation duration have been discussed as potential risk
factors for AKI [1, 9–13]. Both, chronic and acute hyper-
glycemias are associated with cardiac dysfunction, sus-
ceptibility for infections and endothelial dysfunction
[14–18]. These factors are known risk factors of peri-
operative morbidity and mortality after CABG surgery,
in particular of renal dysfunction [1, 9, 11–13, 19–21].
HbA1c is an established parameter for evaluating dia-
betic control and chronic hyperglycemia (CHG) in pa-
tients with DM [22]. Elevated HbA1c levels have been
implemented in recent guidelines [22] and can now be
used for diagnosis of diabetes. Furthermore, HbA1c has
been identified as an important marker for insulin resist-
ance, risk for acute hyperglycemia and endothelial dys-
function and atherosclerosis in diabetic and non-diabetic
patients [14, 16].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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quently used as a marker of cardiovascular risk of individual
patients after cardiac surgery [19–21]. However, informa-
tion on history of diabetes mellitus is often based on self-
reports of patients or from the patient’s records and does
not reflect current glucose control. Furthermore, even pa-
tients without the formal criteria for DM can suffer from
hyperglycemia due to pathological glycemic control or pre-
DM [22]. It is unknown whether preoperative CHG is asso-
ciated with the risk of AKI after cardiac surgery.
In the current study, we aimed to investigate the associ-
ation between CHG and postoperative incidence of AKI
in a cohort of CABG patients, independent from potential
confounders including history of diabetes.
Methods
The study protocol of this prospective cohort study was ap-
proved by the Ethics Committee at the University Hospital
of Würzburg. All patients who received cardiac surgery be-
tween January 1st and December 31st 2009 were screened
for participation. Patients were included if they underwent
CABG surgery or combination procedures including
CABG. Further inclusion criteria were elective or urgent
(start of operation > 6 h after admission) CABG surgery,
and HbA1c-level measured on admission. Exclusion criteria
were operations in which CABG was not planned pre-
operatively, age < 18 years, pregnancy and lactation, ad-
vanced stages of chronic kidney disease (CKD) with a eGFR
<30 ml/min/1.73 m2 according to the creatinine-based
CKD-EPI equation, acute infection (C-reactive protein
>4.0 mg/dl, procalcitonin >1.0 μg/l), high-urgent or salvage
surgery (preoperative resuscitation, i.v. catecholamine ther-
apy started preoperatively, assist device, operation < 6 h
after admission).
The primary endpoint of the present study was defined
as the postoperative incidence of any stage of AKI, accord-
ing to recent KDIGO guideline recommendations [23],
similar to the AKIN - and STS criteria [24]. Thus, even a
slight creatinine level rise of 0.3 mg/dl compared to base-
line within 48 hrs after surgery or Creatinine 1.5 to 1.9-
times baseline (stage I) was defined as AKI. Creatinine
values of blood-samples drawn at hospital admission were
considered as baseline. More severe stages of AKI were a
rise in Creatinine 2.0 to 2.9-times baseline (stage II) and
≥3-times baseline, Creatinine ≥4 mg/dl or the need of renal
replacement therapy (stage III).
Standard demographic data of patients were collected
and comorbidities such as a history of diabetes, hyperten-
sion, pulmonary hypertension and smoking were taken
from the patient’s chart and personal interview. Further-
more, intraoperative data (e.g., operation time, paracorporal
bypass time, aortic cross clamping time, etc.) and standard
laboratory results of clinical routine including HbA1c
measurement at admission were collected. Preoperativechronic hyperglycemia was defined as an HbA1c ≥ 6.0 % on
admission [17, 18, 22]. Postoperative serum glucose (SG)
was taken on admission to the ICU after surgery. Postoper-
ative hyperglycemia was defined as fastening serum glucose
of ≥126 mg/dl during the postoperative course.
Intraoperative data about relevant time-points were taken
from the digital protocol of the heart-lung machine. Met-
formin was stopped 24 hours before admission. For the
purposes of the study, chronic kidney disease (CKD) was
defined as eGFR <60 ml/min.
Statistical analyses
Patient demographics are presented as mean and standard
deviations, medians and interquartile ranges and number of
observations with proportions (%), as appropriate. Differ-
ences across group were assessed by t-test, Mann-Whitney-
U-Test/ and χ2-test/Fisher’s exact test, respectively. Deter-
minants of the postoperative incidence of AKI which were
significant in the univariate analyses (age, history of DM,
HbA1c, eGFR, AF, OP duration, COPD, metabolic syn-
drome and sex) were investigated by logistic regression ana-
lysis. In a sensitivity analysis, we tested the robustness of
the results in a propensity score approach: age, history of
DM, HbA1c, eGFR, AF, OP duration, COPD, metabolic
syndrome and sex were included to assess the probability
of having a HBA1c level >/< 6.0 % by multivariate logistic
regression modelling. These results were included in the
multivariate regression analysis, modelling AKI as a
covariate.
Results of regression analyses are presented as Odds Ratio
with respective 95 % confidence interval (CI). Two-sided p-
values of ≤0.05 were considered as statistically significant.
Statistical analyses were performed using SPSS Version 21.
Results
Patient population
In 2009, a total of n = 928 adult patients underwent cardiac
surgery at the department of cardiovascular surgery at the
University Hospital of Würzburg. Of these, 478 received
elective or urgent CABG surgery. Thirty-nine patients were
excluded because eGFR was less than 30 ml/min, as well as
were two patients with acute infection and 75 high urgent/
salvage surgery patients. Furthermore, no HbA1c measure-
ment within the clinical routine was available for 55 patients.
Therefore the study population consisted of 307 patients.
Patient characteristics of the entire cohort and stratified
according to the established HbA1c cutoff <6.0 % and ≥
6.0 %, respectively) [25], are displayed in Table 1. Patients
had a median age of 69 years, 73.9 % were male A history
of diabetes was observed in 35 % of patients. Metabolic syn-
drome according to the definition of WHO (considering
DM, hypertension, dyslipidemia and BMI) was detected in
254 (82.3 %) of the patients. Thirty-three (10.7 %) patients
were operated with off pump coronary artery bypass
Table 1 Patients characteristics
Variable All patients (n = 307) HbA1c < 6.0 % (n = 142) HbA1c≥ 6.0 % (n = 165) P-value
Age, years 69(60-75) 67(57-74) 70(63-75) 0.008
Male, n (%) 227(73.9) 116 (81.7) 111 (67.3) 0.004
Smoking, n (%) 121(39.4) 47(33.1) 74(44.8) 0.046
LV-EF, % 55(45-63) 55(49-65) 55(45-61) 0.048
Waist circumference, cm 103(±11) 102(±10) 105(±12) 0.047
BMI, kg/m2 28(25-30) 27(25-29) 28(96-113) 0.087
Urgent surgery, n (%) 134(42.6) 70(49.3) 64(38.8) 0.066
MI within the last 48 h, n (%) 25(8.1) 15(10.6) 10(6.1) 0.19
Previous cardiac surgery, n (%) 13(4.2) 6(4.2) 7(4.2) 1.00
Metabolic syndrome, n (%) 254(82.7) 107(75.4) 147(89.1) 0.002
COPD, n (%) 57(18.6) 19(13.4) 38(23) 0.039
History of DM, n (%) 106(34.5) 15(10.6) 91(55.2) <0.001
HbA1c, % 6.0(5.7-6.5) 5.7(5.5-5.8) 6.5(6.2-7.0) <0.001
FSG, mg/dl 105(97-123) 101(95-106) 116(102-138) <0.001
Postoperative SG, mg/dl 143(120-179) 136(117-165) 154(125-188) <0.001
Postop. hyperglycemia, n (%) 209(68.1) 88(42.1) 121(57.9) 0.037
Hypercholesterolemia, n (%) 181(59.0) 80(56.3) 101(61.2) 0.42
Hypertension, n (%) 267(87.0) 122(85.9) 145(87.9) 0.62
Pulmonary Hypertension, n (%) 54(11.3) 16(11.3) 38(23.0) 0.007
AF, n (%) 28(9.1) 8(5.6) 29(12.1) 0.072
TG, mg/dl 128(95-184) 122(89-163) 137(101-205) 0.016
HDL, mg/dl 43(37-53) 44(38-53) 42(35-54) 0.47
LDL, mg/dl 104(82-128) 109(90-135) 98(73-119) <0.001
Preoperative creatinine, mg/dl 1.0(0.8-1.2) 1.0(0.8-1.2) 1.0(0.8-1.2) 0.55
Preoperative eGFRCKD-EPI, ml/min/1.73 m
2 74(59-89) 78(62-100) 72(56-86) 0.010
CKD, n (%) 82(26.7) 29(20.4) 53(32.1) 0.028
OP Duration, min 245(219-295) 240(218-291) 250(219-299) 0.91
CPB Time, min 107(88-143) 105(86-137) 115(88-151) 0.07
X-Clamp Time, min 81(61-104) 78(57-95) 83(63-110) 0.05
Data are mean (±SD), number (%) or median (IQR); LV-EF: left ventricular ejection fraction; BMI: body mass index; MI: myocardial infarction; COPD: chronic
obstructive pulmonary disease; DM: diabetes mellitus; FSG: fastening serum glucose; AF: atrial fibrillation; HDL: high density lipoprotein, LDL: low density
lipoprotein, eGFR: estimated glomerular filtration rate; CKD: chronic kidney disease; X-clamp: aortic cross-clamp; AKI: acute kidney injury
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procedure. Patients with higher HbA1c levels were more
likely to be female and with greater waist circumference.
Furthermore, comorbid conditions, such as smoking, his-
tory of DM, hypertension, pulmonary hypertension and
CKD, were detected more frequently as compared to pa-
tients with lower HbA1c levels (all p ≤ 0.05).
All 106 patients with a history of diabetes were treated
with some kind of diabetes therapy, with 34 % being on
insulin therapy. In only 15 diabetic patients, glucose me-
tabolism was strictly controlled (HbA1c <6.0 %) with a
median FSG of 105 mg/dl. Ninety-one diabetic patients
had HbA1c >6.0 % (median FSG 140 mg/dl) of which 65
had HbA1c levels greater than 6.5 %. None of the pa-
tients without a recorded history of diabetes was treatedwith oral antidiabetics or insulin therapy. However, although
median FSG in this group was 113 (104 – 123) mg/dl,
HbA1c levels >6.0 % were observed in 74 patients, suggest-
ing CHG.
A history of DM was significantly related to postoperative
hyperglycemia regardless of HbA1c (OR 1.46 (1.00 – 2.14),
p = 0,028), whereas acute postoperative hyperglycemia was
not associated with the incidence of AKI (OR 1.00 (1.00 –
1.01), p = 0.96).
Postoperative incidence of AKI
A total of n = 148 patients (49.3 %) experienced AKI
(Table 2). Most of the episodes were stage I (n = 125,
41.1 %) with only a slight increase of serum creatinine. In
23 patients (7.5 %) a more severe increase in creatinine was
Table 2 Outcomes
Variable All patients (n = 307) HbA1c < 6.0 % (n = 142) HbA1c≥ 6.0 % (n = 165) P-value
AKI, n (%) 148(49.3) 57(41.0) 91(56.5) 0.008
AKI Stage I, n (%) 125(41.1) 49(34.5) 76(46.9) 0.005
AKI Stage II, n (%) 22(7.2) 8(5.6) 14(8.6) 0.028
AKI Stage III, n (%) 1(0.3) 0(0) 1(0.6) 0.31
Creatinine Peak, mg/dl 1.3(1.1-1.7) 1.3(1.0-1.6) 1.4(1.1-1.8) 0.014
Mortality, n (%) 10(3.3) 0 10(6.1) 0.002
Data are number (%) or median (IQR) AKI: acute kidney injury
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Patients with HbA1c ≥ 6.0 % were more likely to develop
AKI across all stages, as compared to patients with HbA1c
< 6.0 % (Table 2).
Risk factors of AKI
In univariate logistic regression analysis (Table 3), a his-
tory of diabetes as well as elevated levels of HbA1c were
associated with the incidence of postoperative AKI. Fur-
thermore, older age, impaired kidney function, preopera-
tive atrial fibrillation and prolonged operation time were
significantly associated with an increased risk of AKI (all
p < 0.05). Male gender, FSG and COPD approached sig-
nificance (p < 0.10). In a sensitivity analysis, in which we
included the propensity of each patient as presenting
with a HbA1c level of >6.0 % in the multivariate regres-
sion model for AKI, the results remained largely un-
changed, with a HbA1c level >6.0 % being related to aTable 3 Determinants of postoperative AKI
(logistic regression analysis)
Variable Univariate Multivariate
OR (CI95 %) p-value
Age 1.08 (1.05-1.11) 1.07 (1.04-1.10) <0.001
History of DM 1.85 (1.14-3.00) 1.30 (0.72-2.37) 0.39
HbA1c≥ 6.0 % 1.87 (1.18-2.96) 1.65 (1.00-2.71) 0.049
Preop. eGFR (ml/min) 0.82 (0.72-0.93) 1.00 (0.98-1.01) 0.73
AF 3.05 (1.24-7.49) 2.21 (0.86-5.67) 0.098
OP Duration (min) 1.07 (1.03-1.11) 1.05 (1.01-1.10) 0.013
Sex 1.45 (0.87-2.49) 1.04 (0.58-1.88) 0.89
FSG 1.01 (1.00-1.01) 1.00 (0.99-1.01) 0.73
COPD 1.76 (0.98-3.19) 1.44 (0.76-2.74) 0.26
Post. OP SG 1.00 (1.00-1.01)
Post. OP HG 1.05 (0.83-1.34)
Pulm. Hyper. 1.25 (0.68-2.30) - -
Smoking 1.02 (0.64-1.62) - -
Urgent surgery 0.85 (0.54-1.33) - -
BMI 1.00 (0.96-1.07) - -
Data are OR (95 % CI); eGFR: estimated glomerular filtration rate; AF: atrial
fibrillation; FSG: fastening serum glucose; BMI: body mass index; final model
based on backward stepwise selection; last OR before elimination shownhigher risk of AKI (OR 1.71, 95 % CI 0.90-3.26, p = 0.10),
but this association lost significance (detailed data not
shown).
Mortality
During the hospital stay (median 9 days, IQR 8-12), ten
patients died (3.3 %), with a median time to death of 6 days
(IQR 1-21). Mortality was not significantly associated with
the incidence of AKI (OR: 1.62; 95 % CI: 0.40 – 6.67; p =
0.72). However, all patients who died had HbA1c ≥ 6.0 %
(p = 0.002) as compared to survivors. Further determi-
nants of mortality in univariate analyses were older age,
impaired LV-EF, preoperative eGFR, female gender and
pulmonary hypertension (p < 0.05).
Discussion
The results of our study suggest that aside from older age
and prolonged OP duration, CHG, i.e. elevated HbA1c levels
were associated with the postoperative incidence of AKI
after CABG surgery. This association was independent from
of a history of diabetes, which was only associated with the
risk of AKI in univariate analyses. Furthermore, preoperative
kidney function lost its univariate association with AKI in
multivariate modelling. Even controlling for a multitude of
clinical factors employing a propensity score approach sug-
gested an important role of CHG, although this association
failed to reach formal statistical significance.
This is of particular interest, as usually a history of dia-
betes is used in daily clinical practice for clinical decision
making including the choice of specific operation strategies
as harvesting both mammarial arteries or the extend of the
operation. The easy-to-use laboratory marker HbA1c (as
compared to the time consuming oGTT) not only provides
additional information on the glycemic state of the patient
over the last weeks, it is also an indicator for insulin resist-
ance providing information on perioperative incidences of
hyperglycemia [14]. Markers of impaired glucose metabol-
ism such as elevated HbA1c levels, history of DM and high
levels of FSG were associated with an increased risk of AKI
after CABG surgery in univariate analyses. Postoperative
glucose control is reported as a risk factor for renal impair-
ment after cardiac surgery [14]. In our cohort, we could not
find any strong relation of postoperative hyperglycemia and
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(48 %) was higher than described in recent literature (20 to
40 %) [3, 4, 6, 8, 13]. Compared to these previous studies
we used the rigorous definition of AKI as recommended by
KDIGO guidelines 2012, of even a slight increase of serum
creatinine by 0.3 mg/dl [23]. This definition has also been
implements in the recommendations of the STS [24]; al-
though the changes in creatinine are considerably minor, it
has been shown that they carry important information pre-
dictive for the development of long-term outcome, includ-
ing aggravated risk of the development of CKD as well as
cardiac dysfunction [5, 6]. The preoperative fastening status
might have caused hypovolemia which further could have
sensitized the kidney for intraoperative stress and thus the
development of AKI. However, only few patients experi-
enced severe AKI and only two needed renal replacement
therapy. After multivariate modelling, the association of
HbA1c ≥ 6.0 % with AKI weakened but stayed statistically
significant, suggesting a nearly 1.7-fold increased risk for
patients with CHG independent from the history of DM.
In-hospital mortality was comparable to other studies
(3.3 %) and was not significantly associated with AKI. In
contrast, all patients who died had HbA1c ≥ 6.0 % at admis-
sion, as well as they were older, more likely to be of male
gender, with previous cardiac surgery and prolonged oper-
ation duration in univariate analyses. The overall consider-
ably low mortality-rate did not allow a multivariate analysis
of mortality. Our results suggest that the strict criteria for
AKI might not have a significant impact on the short-term
clinical outcome of patients undergoing CABG surgery,
however, due to limited sample size this interpretation
needs to be taken with caution.
We also found operation time with respective prolonged
duration of CPB and X-Clamp time as another strong and
independent risk factor for the incidence of postoperative
AKI. Per minute prolonged operation time (including CBP
and X-clamp time), the risk of AKI increased by 1 %. Pro-
longed OP duration potentiates inflammatory processes
and the formation of oxidative stress metabolites which are
known to affect kidney function, and promote the develop-
ment of AKI [9, 10, 12]. In our cohort, patients with
OPCAB operations showed a high risk for AKI. Most likely
treatment bias can be considered as the key issue for that
finding – patients were operated OPCAB or beating-heart
on-pump when X-clamping or CPB was impossible due to
severe calcification of the ascending aorta and aortic arch.
We assume that those patients had severe general calcifica-
tion of their arteries, which might also affect renal arteries
and the glomerular convolute. This is also supported by the
fact that patients operated OPCAB or beating-heart on-
pump had a higher prevalence of hemodynamic stenosis of
A. carotis interna (data not shown).
Metabolic syndrome (MS) has been described as a risk
factor for AKI in CABG patients [1]. Only 17.7 % of ourcohort did not fulfill the MS criteria according to the
definition of WHO. We could not show a statistically
signification association of MS and AKI potentially due
to the relatively limited number of observations. DM is
one of the components of MS and can therefore be seen
as an important confounder for the association between
MS and AKI described in other studies [26].
We are aware of several limitations of the current study.
HbA1c values were not kept blinded to the treating physi-
cians, therefore, specific treatment decisions might have
been based on the knowledge of certain HbA1c values
(treatment bias). Furthermore, the size of our study sam-
ple is relatively limited, although a quite large number of
events was observed. Therefore we were not able to assure
sufficient statistical power for all our hypotheses as well as
for the inclusion of other known risk factors of AKI (e.g.
volume management during CPB and medication) in our
multivariate models. We refrained from testing too many
variables in these models, as we wanted to avoid finding as-
sociations by chance (overfitting the model), however, we
might have missed “true” associations by chance as well.
Conclusion
Our data suggest that CHG based on a single measurement
of HbA1c ≥ 6.0 %, could represent a strong determinant of
AKI and mortality after CABG surgery, independent from a
recorded history of DM. This finding might implicate that
treatment decisions, including the selection of operative
strategies, could be based on HbA1c measurement rather
than on a recorded history of diabetes. This applies to pa-
tients with treated diabetes as well as to those without. Fur-
ther prospective studies are needed to confirm our findings
and to investigate how treatment decisions based on
HbA1c levels independent from or in addition to the know-
ledge of diabetic status of the patient might improve clinical
outcomes after cardiac surgery.
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